Unicycive Therapeutics, Inc.UNCYNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
55.12%
↓ 53% below average
Average (6y)
117.31%
Historical baseline
Range
High:499.01%
Low:0.00%
Volatility
425.4%
High variability
| Period | Value |
|---|---|
| 2024 | 55.12% |
| 2023 | 3.75% |
| 2022 | 104.54% |
| 2021 | 499.01% |
| 2020 | 27.67% |
| 2019 | 131.10% |
| 2018 | 0.00% |